MaxCyte Statistics

Total Valuation

MaxCyte has a market cap or net worth of GBP 175.59 million. The enterprise value is 83.14 million.

Market Cap	175.59M
Enterprise Value	83.14M

Important Dates

The next estimated earnings date is Wednesday, August 6, 2025.

Earnings Date	Aug 6, 2025
Ex-Dividend Date	n/a

Share Statistics

MaxCyte has 106.42 million shares outstanding. The number of shares has increased by 1.68% in one year.

Current Share Class	106.42M
Shares Outstanding	106.42M
Shares Change (YoY)	+1.68%
Shares Change (QoQ)	+0.38%
Owned by Insiders (%)	0.95%
Owned by Institutions (%)	68.13%
Float	95.38M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.02
PB Ratio	1.14
P/TBV Ratio	1.16
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.57
EV / Sales	2.85
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.26

Financial Position

The company has a current ratio of 12.23, with a Debt / Equity ratio of 0.09.

Current Ratio	12.23
Quick Ratio	11.29
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	-0.57
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -19.63% and return on invested capital (ROIC) is -13.82%.

Return on Equity (ROE)	-19.63%
Return on Assets (ROA)	-13.12%
Return on Invested Capital (ROIC)	-13.82%
Return on Capital Employed (ROCE)	-23.58%
Revenue Per Employee	255,790
Profits Per Employee	-283,728
Employee Count	114
Asset Turnover	0.15
Inventory Turnover	0.71

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -56.58% in the last 52 weeks. The beta is 1.04, so MaxCyte's price volatility has been similar to the market average.

Beta (5Y)	1.04
52-Week Price Change	-56.58%
50-Day Moving Average	182.27
200-Day Moving Average	272.38
Relative Strength Index (RSI)	30.42
Average Volume (20 Days)	25,539

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MaxCyte had revenue of GBP 29.16 million and -32.35 million in losses. Loss per share was -0.31.

Revenue	29.16M
Gross Profit	23.59M
Operating Income	-39.64M
Pretax Income	-32.35M
Net Income	-32.35M
EBITDA	-36.31M
EBIT	-39.64M
Loss Per Share	-0.31

Full Income Statement

Balance Sheet

The company has 107.02 million in cash and 14.57 million in debt, giving a net cash position of 92.45 million or 0.87 per share.

Cash & Cash Equivalents	107.02M
Total Debt	14.57M
Net Cash	92.45M
Net Cash Per Share	0.87
Equity (Book Value)	154.34M
Book Value Per Share	1.45
Working Capital	110.69M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -24.35 million and capital expenditures -1.16 million, giving a free cash flow of -25.51 million.

Operating Cash Flow	-24.35M
Capital Expenditures	-1.16M
Free Cash Flow	-25.51M
FCF Per Share	-0.24

Full Cash Flow Statement

Margins

Gross margin is 80.91%, with operating and profit margins of -135.94% and -110.92%.

Gross Margin	80.91%
Operating Margin	-135.94%
Pretax Margin	-110.92%
Profit Margin	-110.92%
EBITDA Margin	-124.53%
EBIT Margin	-135.94%
FCF Margin	n/a

Dividends & Yields

MaxCyte does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.68%
Shareholder Yield	n/a
Earnings Yield	-18.42%
FCF Yield	-14.53%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MaxCyte has an Altman Z-Score of 7.19 and a Piotroski F-Score of 1.

Altman Z-Score	7.19
Piotroski F-Score	1